Bioterrorism

Pediatric Annals

Volumn 32, Issue 3, 2003, Pages 154-165

  Cieslak, Theodore J ^a,c   Henretig, Fred ^b  

^a San Antonio Military Pediatric Center   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; ATHRAX VACCINE ADSORBED; ATROPINE; BOTULINUM ANTISERUM; BOTULINUM TOXIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; IMMUNOGLOBULIN; PENICILLIN G; PRALIDOXIME; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; SMALLPOX VACCINE; TETRACYCLINE; TOXIN ANTIBODY; UNCLASSIFIED DRUG; VACCINIA ANTIBODY; YELLOW FEVER VACCINE;

ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ARMY; BIOLOGICAL WARFARE; BOTULISM; BRUCELLOSIS; CHEMICAL WARFARE; CHILD CARE; CHOLERA; CLINICAL FEATURE; DISEASE PREDISPOSITION; FOOD POISONING; HEMORRHAGIC FEVER; HUMAN; INFECTION CONTROL; JAPAN; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PLAGUE; PUBLIC HEALTH; REVIEW; SMALLPOX; TULAREMIA; UNITED STATES; VACCINATION; VACCINATION REACTION; VACCINIA; VIBRIO CHOLERAE; YELLOW FEVER;

EID: 0037340124     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20030301-06     Document Type: Review

References (43)

1. American Academy of Pediatrics, Committee on Environmental Health and Committee on Infectious Diseases. Chemical-biological terrorism and its impact on children: a subject review. Pediatrics. 2000;105:662-670.
2. Okumura T, Takasu N, Ishimatsu S, et al. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med. 1996;28:129-135.
3. Torok TJ, Tauxe RV, Wise RP, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA. 1997;278:389-395.
4. Johnson KM, Martin DH. Venezuelan equine encephalitis. Adv Vet Sci Comp Med. 1974;18:79-116.
5. Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants - Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep. 1997;46:33-35.
6. Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants - Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep. 2000;49:180-184.
7. Dance DB, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis. 1989;159:654-660.
8. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236-2252.
9. Centers for Disease Control. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wklv Rep. 2001;50:909-919.
10. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. JAMA. 2000;283:2281-2290.
11. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2002;285:2763-2773.
12. Centers for Disease Control and Prevention. Update: interim recommendations for antimicrobial prophylaxis for children and breast-feeding mothers and treatment of children with anthrax. MMWR Morb Mortal Wkly Rep. 2001;50:1014-1016.
13. Benavides S, Nahata MC. Anthrax: safe treatment for children. Ann Pharmacother. 2002;36:334-337.
14. Henretig FM, Mechem C, Jew R. Potential use of autoinjector-packaged antidotes for treatment of pediatric nerve agent toxicity. Ann Emerg Med. 2002;40:405-408.
15. Centers for Disease Control and Prevention. Additional options for preventive treatment for persons exposed to inhalational anthrax. MMWR Morb Mortal Wkly Rep. 2001;50:1142,1151.
16. Centers for Disease Control and Prevention. Prevention of plague: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 1996;45(RR-14):1-15.
17. Goldstein JA, Neff JM, Lane JM, Koplan JP. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 1975;55:342-347.
18. Hiss J, Arensburg B. Suffocation from misuse of gas masks during the Gulf war. BMJ. 1992;304:92.
19. Amirav I, Epstein Y, Luder AS. Physiological and practical evaluation of a biological/chemical protective device for infants. Mil Med. 2000;165:663-666.
20. Epstein Y, Linder N, Lubin D, Gale R, Gale J, Reichman B. The incubator as a chemical warfare protective device in neonatal intensive care units. The Israel Journal of Medical Science. 1991;27:648-651.
21. Havlak R, Gorman SE, Adams SA. Challenges associated with creating a pharmaceutical stockpile to respond to a terrorist event. Clinical Microbiology and Infection. 2002;8:529-533.
22. Cieslak TJ, Eitzen EM. Bioterrorism: agents of concern. Journal of Public Health Management Practice. 2000;6:19-29.
23. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR Morb Mort Wkly Rep. 2000;49(RR-4):1-14.
24. Khan AS, Morse S, Lillibridge S. Public health preparedness for biological terrorism in the USA. Lancet. 2000;356:1179-1182.
25. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-1208.
26. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA. 1993;90:2291-2294.
27. Earls JP, Cerva D, Berman E, et al. Inhala-spectrum anthrax after bioterrorism exposure: spectmm of imaging findings in two surviving patients. Radiology. 2001;222:305-312.
28. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933-944.
29. Centers for Disease Control and Prevention. Notice to readers: use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wklv Rep. 2002;51:1024-1026.
30. Bray M, Martinez M, Smce DF, Kefauver D, Thompson E, Huggins JW. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis. 2000;181:10-19.
31. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274.
32. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon. JAMA. 1999;281:2127-2137.
33. 2heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt. Clin Infect Dis. 1996;23:337-340.
34. Arnon SS. Clinical trial of human botulism immune globulin. In: DasGupta BR, ed. Botulinum and Tetanus Naurotoxins: Neurotransmission and Biomedical Aspects. New York, NY: Plenum; 1993:477-482.
35. Cieslak TJ, Henretig FM. Medical consequences of biological warfare: the ten commandments of management. Mil Med. 2001;166(suppl 2):11-12.
36. Committee on Trauma, American College of Surgeons. Initial assessment and management. In: Advanced Trauma Life Support Student Manual. Chicago, III: American College of Surgeons; 1989:9-30.
37. Cieslak TJ, Rowe JR, Kortepeter MG, et al. A field-expedient algorithmic approach to the clinical management of chemical and biological casualties. Mil Med. 2000;165:659-662.
38. Henretig FM, Cieslak TJ, Kortepeter MG, Fleisher GR. Medical management of the suspected victim of bioterrorism: an algorithmic approach to the undifferentiated patient. Emerg Med Clin North Am. 2002;20:351-364.
39. Cieslak TJ, Henretig FM. Biological and chemical terrorism, In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 17th ed. Philadelphia Pa: WB Saunders; 2003.
40. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53-80.
41. Centers for Disease Control and Prevention. Investigating an outbreak. In: Principles of Epidemiology: Self Study Course SS3030. 2nd ed. Atlanta, Ga: Centers for Disease Control and Prevention; 1998:347-424.
42. Medical Management of Biological Warfare Casualties [handbook on CD-ROM]. Fort Detrick, Frederick. Md: US Army Medical Research Institute of Infectious Diseases; 2000.
43. US Army Medical Research Institute of Infectious Diseases, US Food and Drug Administration, Biological warfare and terrorism: medical issues and response [satellite television broadcast]. 2000.